• Explore /
  • Poster
  • / HGCSG 1803: Single-arm phase II study evaluating efficacy of oxaliplatin, irinotecan and S-1 combination therapy (OX-IRIS) in metastatic pancreatic cancer as first-line treatment.

HGCSG 1803: Single-arm phase II study evaluating efficacy of oxaliplatin, irinotecan and S-1 combination therapy (OX-IRIS) in metastatic pancreatic cancer as first-line treatment.

Abstract Poster

Authors

null

Shintaro Nakano

Department of Gastroenterology and Hepatology, Hokkaido University Hospital, Sapporo, Japan

Shintaro Nakano , Yasuyuki Kawamoto , Satoshi Yuki , Kazuaki Harada , Susumu Sogabe , Masayoshi Dazai , Atsushi Sato , Atsushi Ishiguro , Michio Nakamura , Shinya Kajiura , Yasuo Takahashi , Miki Tateyama , Kazuteru Hatanaka , Yasushi Tsuji , Takahide Sasaki , Yoshiaki Shindo , Tomoe Kobayashi , Yuh Sakata , Yoshito Komatsu , Hidenori Karasaki

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2020 ASCO Virtual Scientific Program

Session Type

Poster Session

Session Title

Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary

Track

Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary

Sub Track

Pancreatic Cancer

Clinical Trial Registration Number

jRCTs011190008

Citation

J Clin Oncol 38: 2020 (suppl; abstr TPS4668)

DOI

10.1200/JCO.2020.38.15_suppl.TPS4668

Abstract #

TPS4668

Poster Bd #

276

Abstract Disclosures

Similar Posters

First Author: Nai-Jung Chiang

First Author: Masato Ozaka

First Author: Elisa Giommoni

First Author: Benedikt Westphalen